XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.4
Note 2 – Summary of Significant Accounting Policies (Tables)
6 Months Ended
Oct. 31, 2024
Accounting Policies [Abstract]  
[custom:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock]
          
  

Condensed Consolidated Statement of Operations

For the three months ended October 31, 2023

   
  

Originally

Reported

 

As

Restated

  Change
Change in fair value of derivative liability  $(162,482)  $     $(162,482)
Net loss  $(5,681,328)  $(5,843,810)  $(162,482)

 

          
  

Condensed Consolidated Statement of Operations

For the six months ended October 31, 2023

   
  

Originally

Reported

 

As

Restated

  Change
Change in fair value of derivative liability  $(189,002)  $     $(189,002)
Net loss  $(11,491,676)  $(11,680,678)  $(189,002)

 

          
  

Condensed Consolidated Statement of Stockholders’ Equity

For the six months ended October 31, 2023

   
  

Originally

Reported

 

As

Restated

  Change
Additional paid-in capital  $112,102,691   $114,752,317   $2,649,626 
Accumulated deficit  $(66,078,469)  $(68,758,781)  $(2,680,312)
Total equity  $45,874,875   $45,844,189   $(30,686)
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
   October 31, 2024  April 30, 2024
Customer A   38%    *
Customer B   25%    *
Customer C   *    53%
Customer D   *    24%

Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]
   Level 1  Level 2  Level 3  Total
Convertible notes payable  $     $     $11,911,307   $11,911,307 
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
   October 31, 2024
Issuance date   10/1/2024 
Maturity date   10/1/2026 
Stock price   3.06 
Expected volatility factor   92.8%
Risk-free interest rate   5.21%
Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]
    
Balance, May 1, 2024  $   
Additions   7,681,000 
Fair value measurement adjustments   4,230,307 
Balance, October 31, 2024  $11,911,307 
[custom:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock]
             
  

Three months ended

October 31,

 

Six months ended

October 31,

   2024  2023  2024  2023
Contract related  $     $529,437   $886,440   $840,318 
Product related   1,534,727    3,401,431    3,424,822    4,838,679 
Total  $1,534,727   $3,930,868   $4,311,262   $5,678,997 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   October 31, 2024  October 31, 2023
Series B Preferred Stock, as converted   3,896    3,896 
Stock options   7,896,903    6,861,517 
Warrants   2,292,207    1,539,999 
Restricted stock   1,758,313    779,850 
Total   11,951,319    9,185,262